Stay updated with breaking news from Amgen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New England Asset Management Inc. boosted its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 3.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 18,200 shares of the medical research company’s stock after buying an additional 600 shares during the period. New […]
With its supportive economic development policies, strong infrastructure, talented workforce, and commitment to sustainability, Ohio has become a hub for next-generation biotechnology as well as EVs and other advanced manufacturing.
Jonathan Silverberg, MD, PhD, MPH, discusses how the results of the LEVEL UP trial impact treatment decisions for patients with moderate-to-severe atopic dermatitis.
Visionary Wealth Advisors decreased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 27,758 shares of the medical research company’s stock after selling 263 shares during the quarter. Visionary Wealth […]
Left Brain Wealth Management LLC boosted its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 2.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,013 shares of the medical research company’s stock after purchasing an additional 39 shares during the period. […]